SEARCH:   Advanced

Blood, Vol. 113, Issue 11, 2508-2516, March 12, 2009 This Article Abstract Full Text Services Email this article to a friend Alert me to new issues of the journal Rights and Permissions Citing Articles Citing Articles via CrossRef Mouse models of non-Hodgkin lymphoma reveal Syk as an important therapeutic target Blood Young et al. 113: 2508 Supplemental materials for: Young et al Files in this Data Supplement: Figure S1. Pharmacokinetics of R788 delivered by oral gavage or interperitoneally (JPG, 36.8 KB) - Cohorts of mice were treated with 10 mg/kg of R788 by either oral gavage (Filled Circles) or intraperitoneally (Open Squares). The plasma concentration of the active form of the R788 pro-drug was monitored for 4 hours after treatment. n=3 for each time point, error bars represent standard deviation. This Article Abstract Full Text Services Email this article to a friend Alert me to new issues of the journal Rights and Permissions Citing Articles Citing Articles via CrossRef

	Copyright © 2009 by American Society of Hematology         Online ISSN: 1528-0020